<iframe src="//www.googletagmanager.com/ns.html?id=GTM-T8X5T6" height="0" width="0" style="display:none;visibility:hidden"></iframe> TissueFect Technology Whitepaper

Valleylab™ FT10 Energy Platform TissueFect™ Technology White Paper


Fill out this form to receive instant access to the white paper:


Only available on Valleylab™ generators, TissueFect™ technology is better than ever on the new Valleylab™ FT10 energy platform, our latest advancement in energy-based devices.

Improved TissueFect™ technology means

Explore this white paper to learn how you can benefit from the enhanced TissueFect™ technology within the Valleylab™ FT10 energy platform.


Authors:

Jennifer McHenry, Senior Development Engineer, Medtronic

Jim Dunning, Staff Development Engineer, Medtronic

Katherine Wagle, Senior Development Engineer, Medtronic


Visit our website to learn more about the Valleylab™ FT10 energy platform.

 

 

Ad and Webpage References:

1. As compared to the ForceTriad™ energy platform. Ex-vivo testing model used to evaluate monopolar performance. Based on Covidien ex-vivo monopolar report: “Verification - report - Ex-vivo Monopolar Procedural Flow Evaluation on the Valleylab™ FT10 Orion.” November 2014; R0064443 Rev A.
2. As compared to the ForceTriad™ energy platform. Bench testing model used to evaluate sealing time. Based on Covidien memo: “LigaSure Data Sources for VLFT10 White Papers.” September 2015; RE00025819 Rev A.
3. As compared to the ForceTriad™ energy platform. Based on Covidien product verification report: “Autobipolar Evaluation - Valleylab™ FT10”; February 2015; RE0064455.
4. As compared to the ForceTriad™ energy platform. Bench testing model used to evaluate sealing time. Based on Covidien memo: “LigaSure Data Sources for VLFT10 White Papers.” September 2015; RE00025819 Rev A.>
*Ad Only Reference: Based on the Valleylab™ FT10 Service Manual: part number 1079477, REV 01/2015